Advertisement
Macroscope | Omicron variant uncertainty should put investors off amateur virology
- Investors have enough problems handling more familiar risks without having to speculate about questions epidemiologists are better off addressing
- They are well-advised to confine their predictions to the economy and markets, where there is more than enough uncertainty already
Reading Time:3 minutes
Why you can trust SCMP
1

Here are just some of the things we do not know about the Omicron variant of Covid-19: the severity and transmissibility of infections, the efficacy of the current crop of vaccines against the new strain and the degree to which Omicron has spread around the world.
In short, there is much we do not know about the variant, certainly not enough to gauge its impact on the global economy and financial markets. Yet, this has not stopped investors from reprising their roles as amateur virologists.
Ever since the Covid-19 pandemic erupted, investment banks have produced reams of research on the virus to help determine the level of disruption and its implications for different sectors of the economy and asset prices.
Advertisement
Some of the analysis has been remarkably rigorous, involving assessments of reproduction numbers – the average number of new cases generated by an infected individual – at different stages of the pandemic.
Major providers of financial data, such as Bloomberg and the Financial Times, have tracked infections and deaths and monitored vaccination rates. They have even compiled a “Covid Resilience Ranking” showing where the virus is being handled most effectively with the least amount of economic upheaval.
Advertisement
Advertisement
Select Voice
Select Speed
1.00x

